Search Medical Condition
Please enter condition
Please choose location from dropdown

Al Khobar, Saudi Arabia Clinical Trials

A listing of Al Khobar, Saudi Arabia clinical trials actively recruiting patients volunteers.

RESULTS

Found (8) clinical trials

Low Remifentanil Target Controlled Infusions for Cardiac Surgery

Reducing the time to tracheal extubation and hence the duration of postoperative mechanical ventilation could lessen postoperative complications, improve patients' outcome, shorten the intensive care unit (ICU) stay, and reduce the cost of treatment. Although high-dose opioid cardiac anesthesia has been shown to provide hemodynamic stability and adequate depth of ...

Phase

0.0 miles

Learn More »

Patient-Controlled Epidural Analgesia After Uterine Artery Embolization

The investigators hypothesize that the use of a patient-controlled lumbar epidural analgesia (PCEA) will reduce pain scores and improve patient's satisfaction after uterine artery embolization. The present study is aiming to compare the efficacy of PCEA and continuous epidural infusion of bupivacaine 0.125% with fentanyl 2 g/ml on the quality ...

Phase N/A

0.0 miles

Learn More »

Registry Investigating the Clinical Use and Safety of the Lutonix Drug Coated Balloon for Treatment of BTK Arteries

The study will enroll patients presenting with claudication, or critical limb ischemia (Rutherford Category 3- 5) and an angiographically significant (≥ 70%) native artery lesion appropriate for angioplasty that is below the knee. Subjects will be treated with the Lutonix Drug Coated Balloon (DCB) carrying the CE Mark per current ...

Phase N/A

2.59 miles

Learn More »

Assessment of Switching From Salmeterol/Fluticasone to Indacaterol/Glycopyrronium in a symtomaticCOPD Patient Cohort

This study will investigate whether switching symptomatic COPD patients from a fixed-dose combination of salmeterol/fluticasone 50/500 g b.i.d. to a fixed dose combination of QVA149 110/50 g o.d. leads to improved lung function and airflow. It will also assess the effect on symptom burden, breathlessness, and use of rescue medication ...

Phase

5.65 miles

Learn More »

Biomarker for Niemann Pick Type C Disease

Niemann-Pick disease type C (NPC) is a lipid storage disease that can present in infants, children, or adults. Neonates can present with ascites and severe liver disease from infiltration of the liver and/or respiratory failure from infiltration of the lungs. Other infants, without liver or pulmonary disease, have hypotonia and ...

Phase N/A

9.87 miles

Learn More »

Biomarker for Pompe Disease

Pompe disease is a rare (estimated at 1 in every 40,000 births), inherited and often fatal dis-order that disables the heart and muscles. It is caused by mutations in a gene that encodes an enzyme called alpha-glucosidase (GAA). Normally, the body uses GAA to break down glycogen, the long-term storage ...

Phase N/A

9.87 miles

Learn More »

Biomarker for Morquio Disease

Morquio syndrome (mucopolysaccharidosis type IV; MPS IV) is a mucopolysaccharide stor-age disease that exists in two forms (Morquio syndromes A and B) and occurs because of a deficiency of the enzymes N-acetyl-galactosamine-6-sulfatase and beta-galactosidase, respectively. A deficiency of either enzyme leads to the accumulation of mucopolysaccharides in the body, abnormal ...

Phase N/A

9.87 miles

Learn More »

Biomarker for Maroteaux-Lamy Disease

Maroteaux-Lamy disease (MPS VI) is a lysosomal storage disease inherited in an autosomal recessive pattern. The responsible mutations lie in ARSB (5q11-q13), the gene that encodes the enzyme arylsulfatase B. The phenotype results from defective dermatan sulfate breakdown with lysosomal accumulation. This accumulation of glycosaminoglycans is responsible for the widespread ...

Phase N/A

9.87 miles

Learn More »